Mapping lymph nodes in early ovarian cancer surgery
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a technique to find and remove only the lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It uses a special dye to highlight the sentinel lymph nodes, which may reduce side effects while still checking for spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with early-stage epithelial ovarian cancer (stage I-II).
- You are between 18 and 75 years old.
- You are well enough to undergo surgery (ECOG score 0-1).
- Your blood counts, kidney, and liver function are within normal ranges.
- You are not planning to have children in the future.
- You have not had previous lymph node removal or certain abdominal surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new technique using special dye to help surgeons find and remove the first lymph nodes that drain fluid from ovarian tumors during surgery. This might help doctors better stage your cancer and plan your treatment more accurately.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial studies whether removing lymph nodes in the upper abdomen (hepatoceliac lymph nodes) improves outcomes for people with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer that has spread to those lymph nodes. It also looks at how this surgery works for people with certain types of relapse, often alongside chemotherapy.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
This trial tests a new way to look at lymph nodes during surgery for gynecologic cancers. It may help doctors decide immediately if cancer has spread to the lymph nodes, which could guide treatment decisions during the same operation.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.